[ET Net News Agency, 4 March 2026] HANSOH PHARMA (03692) fell 5% to HK$31.62.
It hits an intra-day low of HK$31.58, hitting an 1-month low, dipping below the 250-D SMA of HK$32.48, and an intra-day high of HK$33.8. The total shares traded was 8.64 million, with a value of HK$279.95m. The active buy/sell ratio is 58:42, with net buying turnover of HK$34.68m. J.P. MORGAN BRO (HK) accounts for greatest net responsive buying turnover of HK$13.18m, with volume weighted average price of HK$32.106. CHINA INNOVATION MARKET SER accounts for greatest net responsive selling turnover of HK$12.53m, with volume weighted average price of HK$32.252. The stock has fallen a combined 9.6% over the past 3 consecutive trading days.
The Hang Seng Index now fell 735 points, or 2.9% to 25,032.
Basic Information| Nominal | 31.620 | % Chg | -4.99% |
| High | 33.800 | Low | 31.580 |
| Shares Tr | 8.64m | Turnover | 279.95m |
| 10-D SMA | 34.824 | %H.V | 33.356 |
| 20-D SMA | 35.961 | VWAP | 32.386 |
| 50-D SMA | 38.063 | RSI14 | 24.990 |
Status: Dipping below the 250-D SMA, hitting an 1-month low, active buy/sell ratio is 58:42, with net buying turnover of HK$34.68m, falling a combined 9.6% over the past 3 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| HANSOH PHARMA (03692) | 31.62 | -4.99 |
| SIHUAN PHARM (00460) | 1.34 | -4.29 |
| GRAND PHARMA (00512) | 7.07 | -2.88 |
| SINO BIOPHARM (01177) | 5.63 | -1.40 |
| HENGRUI PHARMA (01276) | 60.15 | -3.76 |
| LIVZON PHARMA (01513) | 27.30 | -1.80 |
| LUYE PHARMA (02186) | 2.37 | -2.07 |
| FOSUN PHARMA (02196) | 18.24 | -3.08 |
| SH PHARMA (02607) | 11.21 | -2.01 |
| CHINARES PHARMA (03320) | 4.37 | -2.67 |
(ed)
